Latest news
GRCE Stock On Retail Watchlist: High-Stakes FDA Decision On Brain Bleed Drug Nears - StocktwitsStocktwits · Sat, 08 Aug 2026 05:30:26 GMTAXSM Stock In Spotlight Ahead Of Key FDA Verdict On Alzheimer’s Drug This Week - StocktwitsStocktwits · Fri, 07 Aug 2026 07:23:46 GMTVanda Stock Draws Heavy Buzz Ahead Of FDA Verdict On Bysanti For Bipolar, Schizophrenia - StocktwitsStocktwits · Fri, 07 Aug 2026 04:34:06 GMTCapricor's August 22 FDA Verdict Looms as Stock Sits 89% Below Peak - AD HOC NEWSAD HOC NEWS · Wed, 05 Aug 2026 14:44:58 GMTmRNA Flu Vaccine Faces FDA Verdict: Approval Alone Won’t Mean Coverage for Seniors - Tech TimesTech Times · Wed, 05 Aug 2026 13:23:56 GMTReplimune's High-Stakes FDA Verdict: A Biotech Bet Priced for Perfection - AD HOC NEWSAD HOC NEWS · Tue, 04 Aug 2026 16:04:05 GMTReplimune (NASDAQ:REPL) Shares Surge, Gaining Nearly $600 Million in Equity Value Following FDA Decision - TechStock²TechStock² · Fri, 31 Jul 2026 14:01:51 GMTInovio banks $20 million to steady itself before October FDA verdict - thepharmaletter.comthepharmaletter.com · Thu, 30 Jul 2026 07:00:00 GMT